Increased Aβ deposits, Aβ42, Aβ40, Aβ42/Aβ40, p-tau (AT8 and PHF-1), and NFT structures in fAD and DS. Increased CASP3 in DS. This evidence concerns the gene CASP3 and familial Alzheimer disease.